Amendment 0001 Attachment - Questions and Answers.xlsx
XLSX spreadsheet 15 KB Posted
- Solicitation number
- 36C24E27Q0005
About this file
This file is an Amendment Questions and Answers document addressing vendor inquiries related to a VA Medical/Surgical Prime Vendor (MSPV) Supplies Program solicitation for reprocessed non-critical single-use devices (SUDs). The government clarified fifteen key points covering product compliance, eligibility criteria, warranty requirements, country of origin determinations, and operational procedures. Reprocessed products must meet the same Trade Agreements Act (TAA) compliance and Buy American Act requirements as new products. The government confirmed that qualifying FDA-compliant Class I and II reprocessed SUDs are permissible under the solicitation, with the Statement of Work exception superseding the Gray Market and Counterfeit Items clause. The FDA-regulated reprocessor is considered the original equipment manufacturer (OEM) for purposes of this solicitation and may provide warranties and authorization letters in lieu of the original device manufacturer.
Additional clarifications addressed country of origin determinations, which reflect the country where reprocessing occurs rather than the original manufacturing country, and collection and payment activities for eligible used devices will be managed through separate local VA agreements outside the BPA structure. The solicitation limits submissions to pre-defined products on the quote sheet with one part number per product and one distributor per product, eliminating the previously used thresholds of $20,000 in sales, 100 purchase orders, or purchases by 25 stations for product additions. The period of performance for awarded BPAs is five years, and historical 12-month usage and expenditure data are provided in the quote sheet to assist vendors in evaluating demand and supply capacity.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Attachment A - Quote Sheet_36C24E27Q0005_Reprocessed SUDs_V2.zip | ZIP file | |
| 36C24E27Q0005 0001_1.docx | DOCX document | |
| 36C24E27Q0005 0001.pdf | ||
| Attachment A - Quote Sheet_36C24E27Q0005_Reprocessed SUDs_V1.zip | ZIP file | |
| 36C24E27Q0005_1.docx | DOCX document | |
| Attachment C - MSPV Product List Matches.xlsx | XLSX spreadsheet | |
| 36C24E27Q0005.pdf | ||
| Attachment B - Sample Authorized Distributor Letter_36C24E27Q0005.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sheet1 ID Vendor Questions Government Response
| 1 | Please confirm that any reprocessed product still needs to meet the same TAA compliance (USA Origin) parameters as new product. | Yes, all reprocessed products still needs to meet the same TAA compliance parameters as new products. | |
| 2 | I am also curious how MSPO plans to handle the three criteria for addition to the MSPV contract: $20,000 in sales, 100 PO's or purchased by at least 25 stations? | The three criteria mentioned ($20,000 in sales, 100 PO's or purchased by at least 25 stations) was used in the past for new item additions to the MSPV program. These thresholds are no longer being used. | |
| 3 | Section III.B.2 provides an exception for qualifying FDA-compliant Class I and Class II reprocessed single-use devices. However, VAAR 852.212-71, Gray Market and Counterfeit Items (OCT 2026) (Deviation), incorporated on page 20, prohibits used, refurbished, and remanufactured products. | ||
| Could the Government clarify how these provisions are intended to apply together and confirm that qualifying FDA-compliant reprocessed single-use devices are permissible under this solicitation? | The solicitation includes VAAR 852.212-71, as well as, exceptions to this clause in section III B.2 of the statement of work (SOW). This covers resulting BPAs with both new and reprocessed items. The SOW exception language applies in lieu of 852.212-71 for compliant reprocessed items. Qualifying FDA-compliant reprocessed single-use devices are permissible under this solicitation. | ||
| 4 | Section III.C addresses Trade Agreements Act requirements. |
For single-use devices originally manufactured outside the United States but subsequently reprocessed domestically, how will the Government determine the applicable country of origin?
Specifically, does the Government consider FDA-compliant reprocessing to constitute substantial transformation, or will a separate country-of-origin determination be required?
| Additionally, could the Government clarify which domestic preference and trade agreement requirements apply to the proposed products? | Reprocessed items have a new country of origin (COO) based on where the reprocessing takes place. COO is self-certified by the supplier. The Buy American Act and Trade Agreements Act are both requirements of the solicitation, as applicable. | |
| 5 | Section III.B.1 requires supplies to be covered by the manufacturer's warranty. |
For qualifying reprocessed single-use devices, will the Government accept the warranty provided by the FDA-regulated reprocessor in lieu of the original device manufacturer's warranty?
| Additionally, is there a minimum warranty duration or specific warranty documentation required? | The Government will accept the warranty provided by the FDA-regulated reprocessor in lieu of the original device manufacturer's warranty. It must be the normal reprocessor warranty provided for that particular reprocessed item. | |
| 6 | Section III.A.5 requires an Authorized Distributor Letter from the manufacturer covering the duration of the BPA. | |
| For reprocessed devices, can the Government confirm that an authorization letter issued by the FDA-regulated reprocessor satisfies this requirement? | The Government confirms that an authorization distributor letter issued by the FDA-regulated reprocessor satisfies the requirement | |
| 7 | Could the Government confirm the anticipated period of performance for BPAs awarded under this solicitation, including the initial term, any renewal or extension periods, and the anticipated expiration date? | |
| This information is particularly important given the requirement for distributor authorization to remain valid throughout the BPA. | The period of performance of new BPAs will be five years. | |
| 8 | Would the Government be able to provide historical 12-month usage quantities and expenditure data for the products identified in the solicitation's quote sheet? | |
| Understanding historical demand would assist in manufacturing and authorized distributors in evaluating product availability, supply capacity, and competitive pricing. | The 12-month usage is provided under tab 1 columns H & I of the quote sheet. | |
| 9 | The collection of eligible used single-use devices is an important component of supporting a sustainable supply chain. |
Would the Government permit the awardee to establish and maintain collection bins at VA medical centers and healthcare facilities nationwide for eligible single-use devices intended for reprocessing?
| Additionally, would these collection activities be authorized under the resulting MSPV BPA, or would separate agreements, facility-level approvals, or additional contractual arrangements be required? | Separate local VA agreements will be put into place to address the requirements for the collection of eligible single-use devices. | |
| 10 | Would the Government permit an awardee to offer collection credits to participating VA medical centers and healthcare facilities under the resulting MSPV BPA? |
Additionally, could the Government clarify:
| • | Whether collection payments may be issued directly to individual VA facilities or must be administered through a centralized VA agreement. | |
| • | Whether collection payments may be applied toward future purchases of reprocessed devices or must be managed through a separate financial arrangement. | |
| • | Whether collection payments must be disclosed or incorporated into the BPA pricing structure. | |
| • | Whether separate contractual authorization or agreements would be required to establish a nationwide collection-credit program. | Separate local VA agreements will be put into place to address potential collection credits/payments. |
| 11 | We understand that the solicitation limits submissions to one part number per product. However, multiple manufacturers or authorized distributors may offer functionally equivalent reprocessed devices under different catalog part numbers. |
Could the Government clarify how this requirement will be applied when multiple vendors offer equivalent products with different part numbers?
Specifically:
| • | Does the one-part-number limitation apply to each product category, each quote-sheet line item, or each offeror's submission? |
| • | Will the Government accept different manufacturer part numbers for clinically and functionally equivalent products? |
| • | Can offerors submit alternate or equivalent part numbers when the products meet the same clinical and technical requirements? |
| • | If multiple authorized distributors offer the same manufacturer's product, will the Government permit the product to be included under multiple awarded BPAs, or will only one supplier be selected? |
| • | How will the Government evaluate and distinguish equivalent products for BPA award and subsequent MSPV catalog inclusion? |
| Clarification would help ensure that product equivalency, manufacturer identification, and competitive pricing are appropriately addressed in the quotation process. | The government will not be accepting equivalent products with different part numbers in response to this solicitation. This solicitation limits proposed products to the pre-defined list on tab 1 of the Quote Sheet. If multiple authorized distributors offer the same manufacturer's product, only one distributor will be selected for award and the product will be included under one awarded BPA. |
| 12 | Please confirm if it is the VA’s intent to purchase finished, already-reprocessed single-use devices as supplies for the MSPV Product List. Or is the VA seeking reprocessing services for VA-owned devices? | |
| If any part of the requirement includes reprocessing services (for example, collecting used devices from VA facilities, reprocessing them, and returning them), please describe that scope. | The intent of this solicitation is to add finished, already-reprocessed single-use devices as supplies for the MSPV Product List. Reprocessing services will be handled through local VA agreements. | |
| 13 | The quote sheet asks for "OEM Part Country of Origin" (the country in which the supply is manufactured) and TAA compliance. A quoter that reprocesses devices it did not originally manufacture may not know the original manufacturing country for every unit. |
a. For 510(o) reprocessed SUDs, should Country of Origin reflect the original manufacturing country of the device or the country where reprocessing occurs?
b. If the original manufacturing country cannot be determined, how should the quoter report Country of Origin and TAA compliance on the quote sheet?
| c. Will the VA provide the Country of Origin and TAA status it has on file for the current MSPV items listed in Attachment C? The quoter could use that data as its basis for reporting. | The Country of Origin should reflect the country where the reprocessing occurs. | ||
| 14 | Section C.4 (VAAR 852.212-71, Deviation) restricts the procurement to new OEM items and prohibits remanufactured goods. SOW Section B.2 provides an exception for Class I/II SUDs reprocessed under FD&C Act 510(o). Please confirm that the SOW exception governs for this solicitation. | The SOW exception governs for this solicitation. | |
| 15 | Please confirm that the FDA-registered reprocessor is considered the OEM for this solicitation, so that a reprocessor quoting its own reprocessed devices does not need an ADL from the original device manufacturer. | The FDA-registered reprocessor is considered the OEM for this solicitation. |
File details come from the government source that posted it. Updated .